BioCentury | Apr 30, 2012
Emerging Company Profile
Ariel: Antagonizing pain
...rates of non-responders, the pipeline for acute pain continues to be short on novel targets. Ariel Pharmaceuticals Inc....
...first tranche of a $15 million series A round this year. Companies and Institutions Mentioned Ariel Pharmaceuticals Inc....
...York N.Y. RaQualia Pharma Inc. (JASDAQ:4579), Aichi, Japan University of Minnesota , Minneapolis, Minn. Sidebars Ariel Pharmaceuticals Inc....
...first tranche of a $15 million series A round this year. Companies and Institutions Mentioned Ariel Pharmaceuticals Inc....
...York N.Y. RaQualia Pharma Inc. (JASDAQ:4579), Aichi, Japan University of Minnesota , Minneapolis, Minn. Sidebars Ariel Pharmaceuticals Inc....
